Doxercalciferol in Recurrent Pediatric Solid Tumors
Status:
Terminated
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find the highest tolerable dose of
doxercalciferol that can be given to pediatric patients with relapsed solid tumors. The
safety of this drug will also be studied. Another goal is to measure the effect of the study
drug on the blood levels of calcium and vitamin D.